Experimental diabetes induced by alloxan and streptozotocin: The current state of the art

详细信息    查看全文

• 作者：Miroslav Radenković ; ^{mradenkovic@med.bg.ac.rs" class="auth_mail" title="E-mail the corresponding author} ; Marko Stojanović ^{marko.stojanovic@mfub.bg.ac.rs" class="auth_mail" title="E-mail the corresponding author} ; Milica Prostran ^{mprostran@doctor.com" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Alloxan (PubChem CID ; 5781) ; Streptozotocin (PubChem CID ; 29327) ; Phlorizin (PubChem CID ; 6072) ; Nicotinamide (PubChem CID ; 936)
• 刊名：Journal of Pharmacological and Toxicological Methods
• 出版年：2016
• 出版时间：March-April 2016
• 年：2016
• 卷：78
• 期：Complete
• 页码：13-31
• 全文大小：1678 K

文摘

Diabetes mellitus is a chronic metabolic disorder with a high prevalence worldwide. Animal models of diabetes represent an important tool in diabetes investigation that helps us to avoid unnecessary and ethically challenging studies in human subjects, as well as to obtain a comprehensive scientific viewpoint of this disease. Although there are several methods through which diabetes can be induced, chemical methods of alloxan- and streptozotocin-induced diabetes represent the most important and highly preferable experimental models for this pathological condition. Therefore, the aim of this article was to review the current knowledge related to quoted models of diabetes, including to this point available information about mechanism of action, particular time- and dose-dependent protocols, frequent problems, as well as major limitations linked to laboratory application of alloxan and sterptozotocin in inducing diabetes. Given that diabetes is known to be closely associated with serious health consequences it is of fundamental importance that current animal models for induction of diabetes should be continuously upgraded in order to improve overall prevention, diagnosis and treatment of this pathological condition.